John Harrison

Summary

Country: UK

Publications

  1. doi request reprint Notice of failure to disclose financial interest: "A neuropsychological test battery for use in Alzheimer disease clinical trials" (Arch Neurol. 2007;64[9]:1323-1329)
    John Harrison
    Arch Neurol 65:992. 2008
  2. ncbi request reprint A neuropsychological test battery for use in Alzheimer disease clinical trials
    John Harrison
    CPC Pharma Services, PO Box 3223, Warminster, Wiltshire BA12 8XA, England
    Arch Neurol 64:1323-9. 2007
  3. doi request reprint Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
    Lars Lannfelt
    Department of Public Health and Geriatrics, Uppsala University Hospital, Uppsala, Sweden
    Lancet Neurol 7:779-86. 2008
  4. ncbi request reprint Global attentional-executive sequelae following surgical lesions to globus pallidus interna
    Richard B Scott
    Russell Cairns Unit, Radcliffe Infirmary, Oxford, UK
    Brain 125:562-74. 2002

Collaborators

Detail Information

Publications4

  1. doi request reprint Notice of failure to disclose financial interest: "A neuropsychological test battery for use in Alzheimer disease clinical trials" (Arch Neurol. 2007;64[9]:1323-1329)
    John Harrison
    Arch Neurol 65:992. 2008
  2. ncbi request reprint A neuropsychological test battery for use in Alzheimer disease clinical trials
    John Harrison
    CPC Pharma Services, PO Box 3223, Warminster, Wiltshire BA12 8XA, England
    Arch Neurol 64:1323-9. 2007
    ....
  3. doi request reprint Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
    Lars Lannfelt
    Department of Public Health and Geriatrics, Uppsala University Hospital, Uppsala, Sweden
    Lancet Neurol 7:779-86. 2008
    ..Strong preclinical efficacy data and the completion of early, clinical safety studies have preceded this phase IIa study, the aim of which was to assess the effects of PBT2 on safety, efficacy, and biomarkers of AD...
  4. ncbi request reprint Global attentional-executive sequelae following surgical lesions to globus pallidus interna
    Richard B Scott
    Russell Cairns Unit, Radcliffe Infirmary, Oxford, UK
    Brain 125:562-74. 2002
    ..This finding is rare in its specificity and has implications for theoretical models of the functional architecture and pathophysiology of the globus pallidus, and the clinical practice of pallidotomy...